Targeted Biologic Therapies for Severe Asthma: Opportunities and Implications for Managed Care

Gain expert insights on the utilization of targeted biologic therapies in the management of severe asthma, to improve clinical and economic outcomes.
Suzanne G. Bollmeier, PharmD, FCCP, BCPS, AE-C
Geoffrey C. Wall, PharmD, FCCP, BCPS
Format: Microsoft PowerPoint (.ppt)
File Size: 938 KB
Released: May 17, 2022

Acknowledgements

Provided by ProCE, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings